Semaglutide in people with obesity: boosts wellbeing and abili... - 13 May 2021 15:00

BAGSVAERD, Denmark, May 13, 2021 /PRNewswire-AsiaNet/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-...

  Huma raises $130 million financing to scale its digital health... - 12 May 2021 10:01

LONDON and NEW YORK, May 12, 2021, /PRNewswire-AsiaNet/-- The investment arms of leading health and technology companies, Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT, are financing Huma to bring proactive, predictive care to all. Huma Therapeutics [http://www.hum...

  PMB and CEA Announce the Commissioning of iMiGiNE at Frederic ... - 12 May 2021 08:45

PEYNIER, France, May 12, 2021 /PRNewswire-AsiaNet/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020. This disruptive system will revolutionize the radiopharmaceutical production, acces...

  New Global Addiction Recovery and Overdose Prevention App - 11 May 2021 21:00

VANCOUVER, May 11, 2021 /PRNewswire-AsiaNet/ -- BETTER App Available for Download TODAY A new mobile app has been developed to connect people around the world who are seeking recovery from addiction with a support community that wants to help - potentially saving lives. Logo - https://mma...

  Zymo Research Releases Open-Source Bioinformatics Pipeline for... - 11 May 2021 19:05

IRVINE, Calif., May 11, 2021 /PRNewswire-AsiaNet/ -- -- Early Release of the VirSieve(TM) Bioinformatics Pipeline Will Promote Collaboration in Environmental SARS-CoV-2 Research Zymo Research has released the VirSieve(TM) Bioinformatics Pipeline ( https://c212.net/c/link/?t=0&l=en&o=3158...

  Hong Kong government endorses INDICAID(R) in visitation resump... - 11 May 2021 10:00

HONG KONG, May 11, 2021 /PRNewswire-AsiaNet/ -- COVID-19 rapid antigen test (RAT) INDICAID(R), developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation on...

  Objective Acuity announces successful pilot study in children ... - 11 May 2021 05:00

AUCKLAND, New Zealand, May 11, 2021 /PRNewswire-AsiaNet/ -- Objective Acuity ("OAL") today announced the completion of a pilot study using OAL's threshold visual acuity test for young children diagnosed with late-infantile neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a form of Batten disease. A...

  deCODE genetics - Rounding off the human genome - 11 May 2021 01:00

REYKJAVIK, Iceland, May 11, 2021 /PRNewswire-AsiaNet/ -- In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits. Vi...

  Novavax Announces Positive Preclinical Data for Combination In... - 11 May 2021 00:09

GAITHERSBURG, Md., May 11, 2021 /PRNewswire-AsiaNet/ -- - Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 virus - Data shared via preprint server for biology, bioRxiv, ahead of publication Novavax, Inc. (Nasdaq: NVAX), a b...

  The Firm of John Dickinson Schneider, Inc. Commemorates 100th ... - 11 May 2021 00:00

LIBERTYVILLE, Ill., May 11, 2021 /PRNewswire-AsiaNet/ -- Hollister Incorporated and KMT Medical celebrate Founder's Day today, recognizing the 100th anniversary of their parent company, The Firm of John Dickinson Schneider Inc. (JDS Inc.). A commemorative event celebrating the founder of JDS Inc., John ...